Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.01969
Abstract: Recent small-scale clinical trials have shown promising results in the use of hydroxychloroquine, an FDA approved anti-malaria drug, for the treatment of COVID-19. However, large scale, randomized and double-blind clinical trials are needed to confirm… read more here.
Keywords: game changer; still game; covid; clinical trials ... See more keywords